ICG Administration
Cross-source consensus on ICG Administration from 1 sources and 5 claims.
1 sources · 5 claims
Dosage & preparation
Risks & contraindications
Highlighted claims
- ICG is administered intravenously 24 hours before surgery in an outpatient day-hospital setting. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- Patients with cirrhosis or previous systemic chemotherapy receive 0.2 mg/kg of ICG intravenously. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- Eligible patients without cirrhosis or previous systemic chemotherapy receive 0.5 mg/kg of ICG intravenously. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- ICG dose is adjusted according to liver background and treatment history. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- Adverse events are recorded after ICG administration. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial